Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from MarketBeat

Palantir's Critics Are "Right"—But They're Also Still Wrong

Palantir stock pulled back after earnings, but PLTR’s explosive revenue growth and rising analyst targets suggest the bull case remains intact

MarketBeat

Canadian Solar Q1 Earnings Call Highlights

Canadian Solar (NASDAQ:CSIQ) reported first-quarter 2026 revenue at the high end of its forecast and a stronger-than-expected gross margin, helped by tariff refund accruals, while the company still posted a net loss amid higher operating costs, foreign exchange losses and tax expense accruals. Exec

MarketBeat

CorMedix Q1 Earnings Call Highlights

CorMedix (NASDAQ:CRMD) reported sharply higher first-quarter 2026 revenue and profit, driven by continued adoption of DefenCath and the addition of products from its Melinta acquisition, while management raised its full-year financial outlook and outlined key pipeline developments. Chairman and Chi

MarketBeat

From analysis to the latest developments in health,
read the most diverse news in one place.

Cellebrite DI Q1 Earnings Call Highlights

Cellebrite DI (NASDAQ:CLBT) reported first-quarter 2026 results that management said met or exceeded the high end of its guidance for annual recurring revenue and adjusted EBITDA, while executives highlighted a wave of new product launches centered on artificial intelligence, cloud-based case manage

MarketBeat

Bitdeer Technologies Group Q1 Earnings Call Highlights

Bitdeer Technologies Group (NASDAQ:BTDR) reported sharply higher first-quarter revenue as its Bitcoin mining output expanded, while management emphasized a broader push into AI cloud services and large-scale data center colocation. On the company’s first-quarter 2026 earnings call, Chief Strategy O

MarketBeat

Autolus Therapeutics Q1 Earnings Call Highlights

Autolus Therapeutics (NASDAQ:AUTL) reported higher first-quarter 2026 product revenue and said its commercial launch of AUCATZYL is gaining traction in the U.S. and U.K., while reiterating full-year revenue guidance for the cell therapy. Chief Executive Officer Dr. Christian Itin said the company h

MarketBeat

BioHarvest Sciences Q1 Earnings Call Highlights

BioHarvest Sciences (NASDAQ:BHST) reported higher first-quarter revenue and reiterated its 2026 outlook as management detailed a broader reorganization around two business lines: its direct-to-consumer VINIA products business and its contract development and manufacturing organization, or CDMO, plat

MarketBeat

Read news from The Economist, FT, and more,
with one subscription

Aquestive Therapeutics Q1 Earnings Call Highlights

Aquestive Therapeutics (NASDAQ:AQST) said it remains on track to resubmit its new drug application for Anaphylm, its epinephrine sublingual film for severe allergic reactions, in the third quarter of 2026, while reporting higher first-quarter revenue and a narrower net loss. On the company’s first-

MarketBeat

Aebi Schmidt Q1 Earnings Call Highlights

Aebi Schmidt (NASDAQ:AEBI) reported higher first-quarter 2026 order intake, sales and profitability, with management pointing to strong demand in Europe and the rest of the world, improving walk-in van activity in North America and a record backlog that supports its full-year outlook. The company s

MarketBeat

Chime Finally Turns Profitable—But Risks Remain

Chime Financial delivered its first profitable quarter as revenue growth, margin expansion, and loan growth strengthened the fintech’s future prospects.

MarketBeat

eVTOL Investing: Ditch the Taxi, Buy the Blueprint

As the eVTOL sector moves from concept to reality, the focus shifts to capital-efficient business models and the de-risked path to commercialization.

MarketBeat

AeroVironment CEO Says Drone Warfare Shift Is ‘Our Moment’ as Defense Demand Builds

AeroVironment (NASDAQ:AVAV) Chairman, President and CEO Wahid Nawabi said accelerating global security threats are reshaping defense priorities toward drones, loitering munitions and counter-unmanned aircraft systems, areas where he said the company is well positioned. Speaking at a Bank of America

MarketBeat

Resideo Technologies Q1 Earnings Call Highlights

Resideo Technologies (NYSE:REZI) reported first-quarter 2026 results above its outlook ranges and reaffirmed its full-year guidance, as executives cited solid execution across both its Products and Solutions and ADI Global Distribution businesses despite inflationary pressures and soft end markets.

MarketBeat

Reinsurance Group of America Q1 Earnings Call Highlights

Reinsurance Group of America (NYSE:RGA) reported a strong first quarter of 2026, with management pointing to broad-based earnings strength across regions, favorable claims experience and continued capital deployment into new business opportunities. On the company’s earnings call, President and Chie

MarketBeat

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

AIRO Group Q1 Earnings Call Highlights

AIRO Group (NASDAQ:AIRO) reported first-quarter 2026 revenue that declined from the prior year, while management said the results were in line with internal expectations and reaffirmed its full-year revenue growth outlook as the company shifts more of its focus toward drones. On the company’s earni

MarketBeat

Versant Q1 Earnings Call Highlights

Versant (NASDAQ:VSNT) Media Group reported a modest revenue decline in its first quarter as an independent company, while management pointed to stronger profitability, growth in digital and platform businesses, and continued investment in direct-to-consumer offerings as key priorities for 2026. Chi

MarketBeat

RPC Q1 Earnings Call Highlights

RPC (NYSE:RES) reported higher first-quarter 2026 revenue as activity improved across most service lines despite winter storms early in the period, while profitability was pressured by job mix, fuel costs and working capital needs. President and CEO Ben M. Palmer said demand strengthened as the qua

MarketBeat

Accelerant Q1 Earnings Call Highlights

Accelerant (NYSE:ARX) reported stronger-than-expected first-quarter 2026 results, with management pointing to continued growth in its specialty insurance platform, expanding third-party insurer participation and increased use of artificial intelligence across underwriting and internal operations. C

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

How Berkshire’s New York Times Bet Looks Today

Berkshire Hathaway has backed one of the world's most well-known news outlets: the New York Times. See what is to make of Berkshire's latest bet.

MarketBeat

Affirm's Google Deal Aims for Your Wallet

Affirm's landmark deal with Google seamlessly integrates its popular buy-now-pay-later financing options directly into the vast Google Pay platform.

MarketBeat

Astec Industries Maps 2030 Growth Plan, Targets Higher Margins at Investor Day

Astec Industries (NASDAQ:ASTE) used its 2026 Investor Day to outline a five-year growth plan centered on higher recurring revenue, digital products, operational improvements and disciplined acquisitions. President and CEO Jaco van der Merwe said the Chattanooga, Tennessee-based equipment manufactur

MarketBeat

Dr. Reddy's Laboratories Q4 Earnings Call Highlights

Dr. Reddy's Laboratories (NYSE:RDY) reported what Chief Financial Officer M.V. Narasimham described as a resilient FY 2026 performance, with record annual revenue despite pressure from lower lenalidomide sales and several one-time charges during the fourth quarter. Narasimham said the company’s und

MarketBeat

Radian Group Q1 Earnings Call Highlights

Radian Group (NYSE:RDN) said its first quarter of 2026 marked the company’s first reporting period as a “global multi-line specialty insurer” following the early February closing of its $1.7 billion acquisition of Inigo, a specialty insurance carrier operating through the Lloyd’s market. Chief Exec

MarketBeat

Ralliant Q1 Earnings Call Highlights

Ralliant (NYSE:RAL) reported first-quarter 2026 results above the high end of its guidance and raised its full-year outlook, citing strength in Test & Measurement, continued demand in defense and utilities, and early benefits from productivity initiatives. President and CEO Tami Newcombe said t

MarketBeat

Redwire Q1 Earnings Call Highlights

Redwire (NYSE:RDW) reported sharply higher first-quarter 2026 revenue and record backlog, while management said the company is increasing internal research and development spending to pursue larger opportunities across space and defense markets. Chairman and CEO Peter Cannito said Redwire saw “stro

1 … 24 25 26 27

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.